NSI-189 vs Semax

NSI-189 wins for slow structural neurogenesis, persistent post-cycle effects, and targeting deep anhedonia or hippocampal volume loss. Acts as a true builder—its impact accumulates over weeks and outlasts administration.

Semax wins for immediate BDNF/NGF upregulation, fast onset, flexible cycling, and stress resilience without monoamine baggage. Semax's intranasal delivery gives precision and convenience, with almost zero systemic side effects observed at standard doses.

Pick NSI-189 if:

• The goal is long-term reversal of cognitive deficits or post-SSRI anhedonia
• Protocols prioritize structural hippocampal recovery or neurogenesis
• A durable effect that persists well after the cycle is desired
• A compound with minimal acute side effects, suitable for longer cycles, is needed
• A research context is focused on chronic mood recovery or neurorestoration

Pick Semax if:

• Rapid cognitive enhancement or sharper focus is the priority
• Mood-lifting, anti-stress, or post-concussion support is needed with minimal latency
• Intranasal delivery is preferred for convenience and fine-tuning acute response
• The cycle is short and demand flexible, e.g. pre-task or peri-cycle mood support
• Compounds that don't impact monoaminergic tone or cortisol output are necessary